Maynard Um
-
-
-
-
-
-
-
Personalis presents clinical data on cancer monitoring technology at AACR
-
-
-
-
-
-
-
Personalis study shows ctDNA test detects immunotherapy response early
-
-
-
-
-
-
-
Personalis lung cancer test shows higher sensitivity in clinical trial
-
-
-
-
-
-
-
Personalis (PSNL) PT Lowered to $7 at BTIG
-
-
-
-
-
-
-
Personalis, Inc. (PSNL) Misses Q3 EPS by 29c, Beats on Revenue
-
-
-
-
-
-
-
Personalis (PSNL) PT Raised to $5.50 at BTIG
-
-
404,872 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

